Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study of Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer

K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
ovarian-cancer
ovarian cancer, platinum-resistant ovarian cancer, primary peritoneal carcinoma, fallopian tube cancer, wee1, wee-1, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 854046
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.